The world extremity reconstruction market was $1,833 million in 2015 and is expected to reach $3,041 million by 2022, growing at a CAGR of 7.5% from 2016 to 2022. Extremity reconstruction devices are used to treat, repair, replace, or heal extremity injuries such as fractures or damage. The extremity reconstruction market covers implant devices for the shoulder, elbow, wrist, digits, foot, and ankle joints. The market is segmented based on the product type into upper extremity reconstruction devices and lower extremity reconstruction devices. The extremity reconstruction segment holds a small share in the global orthopedic market but it is expected to grow at the fastest rate during the study period. Hence, the leading companies have increased their focus on the segment to overcome the sluggish growth in the hip and knee joint reconstruction market.

Browse Full Report Visit – http://www.acutemarketreports.com/report/extremity-reconstruction-market

TOP INVESTMENT POCKETS

Shoulder reconstruction and ankle replacement are the potential target areas for investment by the key players in the extremity reconstruction market. Shoulder reconstruction is the highest revenue-generating segment in this market owing to rise in joint-related disorders, technological advancements such as reverse shoulder and stemless shoulder implants and large patient population. Recent developments in the market such as approval of stemless shoulder implant, Simpliciti by Wright Medical, in the U.S, increasing adoption rate of reverse shoulder implants and increasing use of natural biomaterial to improve the osseo-integration rate and the strength of bone-prosthetic bonding are expected to strengthen the market. Stemless shoulder replacement is ideal for patients with post-traumatic osteoarthritis of the shoulder and extra-articular deformities of the proximal humerus, which can make the placement of a conventional stemmed prosthesis difficult or impossible. For patients with massive irreparable rotator tear, who cannot opt for conventional total shoulder replacement, reverse shoulder replacement has emerged as a boon.

The ankle replacement segment is expected to exhibit momentous growth in the extremity reconstruction market due to increasing adoption rate in developed economies and restoration of range of movements of the ankles. In addition, technological advancements such as three-part mobile bearing un-cemented total ankle replacement devices, growing incidences of ankle arthritis and development of less invasive techniques are further expected to propel the market. With encouraging results of pipeline products and increasing number of regulatory approvals for the total ankle replacement devices, the future for the ankle replacement market seems bright.

Browse All Reports of This Category – http://www.acutemarketreports.com/category/medical-equipments-market

Increasing incidences of joint disabling diseases, trauma and sports injuriesWith improvements and advancements in healthcare facilities, there has been an increase in life expectancy across the globe. As estimated by Global Health and Ageing Report, WHO 27% of the Japanese, 16% of the American, 24% of the British, 17% of the Russian, and 14% of the Chinese population will be above 65 years of age by 2020. Due to aging, there is an increasing prevalence of joint disorders. According to the Centers of Disease Control and Prevention, with an increase in the aging population in the U.S., the number of patients suffering from arthritis is expected to increase to 78 million by the year 2040. The prevalence of osteoarthritis increases indefinitely with age, as the condition is irreversible. Cases of trauma and sports injury are also increasing. According to the National Center for Health Statistics, in 2011, 77% of all injury health care visits were for musculoskeletal injuries. Hence, the demand for extremity reconstruction devices is expected to increase globally.

Technological advancements in the field of extremity implantsContinuous technological innovations in the field of extremity implants and surgery, such as stemless shoulder implant, reverse shoulder implant, mobile bearing ankles, and new implant materials with better safety are set to drive the market for extremity implants. For instance, advancements in ankle joint replacement provide surgeons with more options when treating ankle arthritis and also increase the longevity of the implants. Recent success in total elbow arthroplasty with the development of devices such as Comprehensive Segmental Revision System from Zimmer Biomet has provided solutions for implant failures. Small startup companies are developing innovative technologies such as development of minimally invasive endoscopic techniques for extremity implants which has also reduced the recovery time and pain. For instance, Instratek launched HammerFIT Extremity Reamer System for hammertoe surgery.

Increasing awareness and patient preference to maintain an active lifestyleThe extremity reconstruction is the fastest growing segment of reconstructive joint replacement market. This is mainly due to increasing awareness and preference of patients to maintain an active lifestyle after joint disorders and trauma or injury. According to the Centers for Disease Control and Prevention, in 2012, there were 65,000 shoulder replacement procedures performed in the U.S. Furthermore, according to the National Institute of Health, there has been a 393% increase in the total shoulder arthroplasty procedures performed from 2001 to 2010 due to increasing awareness.

Obesity and diabetes epidemic increasing the risk of degenerative joint diseasesAliments such as diabetes and obesity increase the risk of degenerative joint disease manifold. It is estimated that about 285 million people suffered from diabetes in 2010, and this is estimated to increase to 438 million by 2030 [Report Global Burden of Disease, WHO]. People with diabetes are at an increased risk of osteoporosis and joint disorders. Similarly, a person with obesity is around 60% more likely to develop arthritis and other joint disorders.

The key players profiled in the report include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.

Key Market Segments

The Global extremity reconstruction market is segmented based on product, applications, biomaterial and geography.

Extremity Reconstruction Market By ProductUpper Extremity ReconstructionShoulderPartial Shoulder ReplacementTotal Standard ReplacementStemless Total Shoulder ReplacementTotal Reverse ReplacementElbowHand & WristLower Extremity ReconstructionFoot DevicesHind foot FusionOther FusionsAnkle Reconstruction DevicesAnkle FusionAnkle ReplacementExtremity Reconstruction Market By BiomaterialMetallic BiomaterialCeramic BiomaterialPolymeric BiomaterialNatural Biomaterial

Extremity Reconstruction Market By GeographyNorth AmericaU.S.CanadaMexicoEuropeGermanyFranceU.K.ItalySpainRest of EuropeAsia-PacificJapanChinaIndiaSouth KoreaMalaysiaRest of Asia-PacificLAMEABrazil IsraelSouth AfricaSaudi ArabiaOthers

Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Research methodology
1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO Perspective

Chapter: 3 MARKET OVERVIEW
3.1 Market Definition & Scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies
3.3 Porter’s Five Forces Analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes
3.4 Market Share Analysis, 2015
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Increasing incidences of joint disabling diseases, trauma anD sports injuries
3.5.1.2 Technological advancements in the field of extremity implants
3.5.1.3 Increasing awareness and patient preference to maintain an active lifestyle
3.5.1.4 Obesity and diabetes epidemic increasing the risk of degenerative joint diseases
3.5.2 Restraints
3.5.2.1 High cost of surgeries
3.5.2.2 Failure, complications, and revision of surgeries and lack of trained professionals
3.5.3 Opportunities
3.5.3.1 Huge market opportunities in the Asia-pacific region and developing countries
3.5.3.2 New product introductions with innovative technologies

Browse For Complete Report Here : Extremity Reconstruction Market 2016

Chapter: 4 WORLD EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Upper Extremity Reconstruction
4.2.1 Key market trend
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Shoulder Replacement
4.2.4.1 Market size and forecast
4.2.4.2 Partial Shoulder Replacement
4.2.4.2.1 MARKET SIZE AND FORECAST

Latest Reports

World 3D Printing Market – Opportunities and Forecasts 2014 – 2020

Mobile Security Asia-Pacific Market Research Report, 2014 – 2020

Asia-Pacific LED Market – Opportunities and Forecast, 2014 – 2020
About – Acute Market Reports :

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us : 
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com

The post World Extremity Reconstruction Market Size, Application Analysis, Growth Trends and Forecasts 2016 – Acute Market Reports appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3608

September 30, 2016 – – PEAK Longevity and Regenerative Medicine™ has announced a revolutionary metabolic conditioning program that reinvigorates the slowed metabolism associated with aging to help re-ignite fat and carbohydrate utilization to more youthful levels. The program increases energy and does not require starvation diets or intense workouts for results as the body’s metabolism is, once again, doing most of the work burning calories.

“Your body at base level is a machine, not unlike your car,” says Dr. Osborn. “Similarly, it has an engine that generates heat. This engine is known as your metabolism,” he continues. “Sugar is a known metabolic toxin and shuts down the fat burning process, exactly what you are trying to avoid!” he explains. Dr. Osborn instead prescribes a customized, low-glycemic index, macronutrient-based nutrition regimen that is easy to follow. “After in-depth blood work and analysis, the strategy is to assist the body in stoking the flames of your metabolism instead of starving you like many of the mainstream programs advertised in 30-second TV spots. Those diets typically fail long-term by causing the metabolism to slow to a snail-like pace.”

PEAK’s Weight Loss System feeds your metabolism with food that it craves, as a car engine does high-octane gasoline and synthetic oil. Dr. Osborn encourages patients to eat more not less. “The key,” Dr. Osborn says, “is to trick your body into a calorie-restricted state during which it burns predominantly fat for energy, while concomitantly accelerating the metabolic rate.” The body therefore calls upon its own fat stores to meet energy demands, as does the hibernating bear, albeit without the metabolic slowdown.

This metabolic conditioning is accomplished by eating the right types of foods in just the right quantities at the right times. Interestingly, patients initially report being challenged eating enough on this program with the faster metabolic rate.

For more information on this PEAK’s medically backed weight loss system, visit www.PEAKLARM.com or contact the office: 561-935-9233.

###

Contact Peak Longevity and Regenerative Medicine:

Dr. Brett Osborn
561-935-9233
drbrettosborninfo@gmail.com
600 Heritage Dr. Suite 105

ReleaseID: 60012642

September 30, 2016 – – TheProductLawyers.com provides details on the latest developments in the many lawsuits filed against the makers of Xarelto. With more than 2,000 cases already filed against Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer AG, the federal Judicial Panel on Multidistrict Litigation elected to consolidate them. This consolidation of cases into MDL No. 2592 will expedite the process of law and ensure a resolution is reached more swiftly. The litigation will be carried out in the Eastern District of Louisiana under the supervision of Judge Eldon Fallon.

However, prior to the main case hearings, four bellwether cases have been selected. These will enable counsel to observe the reactions of jury panels to presented evidence and testimony. The first and second cases will be presented in the Eastern District of Louisiana on February 6th and March 13th of 2017. The third and fourth cases have been relocated to other districts, and will be heard on April 24th and May 30th of 2017.

Initially following its 2011 FDA approval, Xarelto was hailed as a breakthrough in the treatment of blood clots. However, after several years it receives a somewhat lackluster appraisal from both patients and physicians. In fact, the plaintiffs allege that the new-generation blood thinner placed them at a substantially elevated risk for catastrophic bleeding episodes and that the manufacturers were negligent in their responsibility to apprise both doctors and the public of this risk.

While the litigation moves forward in the Eastern District of Louisiana, the Philadelphia Court of Common Pleas has also consolidated Xarelto lawsuits into a mass tort program. Comprised of 550 separate suits with allegations of harm leveled against the pharmaceutical companies, the mass tort program claims are similar to those of MDL No. 2592.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012384

September 30, 2016 – – GraceKennedy Limited, a leading Caribbean food manufacturer, and distributor since 1922, has recently launched their dry coconut milk powder on the online shopping portal Amazon.com. Based on customer reviews, their dry coconut milk powder is proving to be the perfect solution for those who like to go camping or backpacking.

Being a dry product available in sachets, the dry milk powder is easy and lightweight to carry in a backpack. Due to its size, it takes up almost no space, which means it is very easy for packing. During backpacking or camping trips, the dry coconut milk powder can be used as a creamer for coffee or tea. It can also be used for common recipes while cooking at campfires – a great substitute for milk.

“We love to read customer reviews and get feedback from our buyers on how they are using the coconut milk powder. To our surprise, there was a large amount of buyers that were using the dry coconut milk powder in various other ways other than the standard recipes, in particular when backpacking or camping,” said Deidre, a company representative.

“…I had never tried coconut powder before. It is delicious! I love how versatile this product is. You can make coconut milk and cream by just adding water. Really nice to use in the RV or trailer, to go camping or even save in your survivalist section of the pantry,” said Mema, a satisfied customer.

Sunshine, another satisfied customer shared her satisfaction as well, “I bought this to put in dehydrated backpacking meals – curry, stroganoff, etc. The taste is good and it’s very convenient to use. The packages came promptly and were well packaged (no split packets, etc.). Will be buying this again.”

The dry powdered milk is proving to be very popular on Amazon, already collecting over 30 reviews with a 4.9 out of 5.0-star rating. The coconut milk powder can be purchased in packs of 3, 6 or 12 based on buyer’s needs.

###

Contact GraceKennedy:

GraceKennedy
876-922-3440
gracefoods@gkco.com
73-75 1/2 Harbour St.
Kingston 10, Jamaica

ReleaseID: 60012567

September 30, 2016 – – GraceKennedy Limited, the Caribbean’s leading food manufacturer and distributor in Jamaica is proud to announce that their Jamaican Jerk Seasoning has reached a milestone of 130 reviews on Amazon.com. Since launching their Jamaican Jerk Seasoning on Amazon, the reviews for the seasoning hold a ranking of 4.8 out of 5.0 stars.

Deidre, a company representative, says: “We’re so happy to see that our customers love our jerk seasoning. We have tried to create something truly authentic so that people from all over the world can have a real taste of Jamaica, and it is really good to see that we’re achieving that. Keep the reviews coming, and keep telling us how you have been using our jerk seasoning.”

The seasoning is being hailed for its authentic taste. The Grace brand is well known all over the island and now that it is available in the USA via Amazon.com, it is quickly growing in popularity. The taste of the seasoning is truly unique and exotic, thanks to the native Jamaican herbs and spices. This makes the flavor truly genuine.

Jerk seasoning can be used in a range of different ways. While jerk chicken is perhaps the best-known recipe, it can also be turned into a rub for beef, fish, shrimp, or pork. Additionally, it can be turned into a marinade to really infuse the meat with its beautiful flavors.

One of the things that reviewers have been particularly pleased with is the free recipe e-book that is emailed after every purchase. It is filled with unique recipes for jerk barbecue shrimp, jerk pineapple chicken, jerk chicken, and more. The collection enables people to have a little piece of Jamaica in their own home.

“Love this product. Makes the best Jamaican Jerk chicken. I marinate it at least 24 hours and everyone comments on how good it is. Product always arrives sealed and packaged well within 2 days with Prime. Highly recommended,” said William P, a satisfied customer.

“True Jamaican jerk is incredibly spicy,” adds Deidre. “Not everybody is able to cope with that, and not everybody enjoys it either, which is why we have made our jerk available in both hot and mild to suit any palate.”

The Grace Jerk Sauce is currently available on Amazon.com in an eleven-ounce bottle that provides the customer with a suitable amount of sauce for their cooking pleasure. The product can be bought in a 1-pack, 4-pack or 12-pack to suit the needs of the consumer.

###

Contact GraceKennedy:

GraceKennedy
876-922-3440
gracefoods@gkco.com
73-75 1/2 Harbour St.
Kingston 10, Jamaica

ReleaseID: 60012568

September 30, 2016 – – TheProductLawyers.com reports on a recent article by HarrisMartin Publishing indicating that six new lawsuits have been filed in various states against Johnson & Johnson.

The source said that lawsuits have been filed in Illinois, Georgia, Ohio, Texas, and Florida. The sixth complaint, according to the article, was removed to a Florida federal court, after it was originally filed in a state court in April.

The product was widely popularized as a feminine hygiene product that women would often use to sprinkle the lining of their underwear. Over the last 45 years numerous studies have found that women who use baby powder as a feminine hygiene product are more likely to develop this debilitating disease. Other studies, however, have not found a definitive link between the two.

Many women in the U.S. have made claims alleging that Johnson & Johnson hid valuable medical information that prevented consumers from knowing the dangers of using the powders. Those plaintiffs further claim that the use of Johnson & Johnson’s powders as a feminine hygiene product are directly linked to ovarian cancer. Johnson & Johnson has denied claims that their products cause cancer and has stated that no causal link exists.

As these lawsuits are expected to grow in numbers, Banville Law is seeking to help those currently suffering. The firm has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed. Attorneys at Banville Law want to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.

For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012481

September 30, 2016 – – This is the most significant change to the Federal Centers for Medicare and Medicaid (CMS) rules governing federal funding of long-term care facilities in 20 years. The move will help prevent facilities from blocking various claims due to arbitration clauses.

Parker Waichman LLP, a national law firm long dedicated to protecting the rights of victims of nursing home abuse and neglect, is commenting on a cases initially blocked from court and a new rule that will affect nursing homes and some 1.5 million residents. The new protection is meant to prevent this type of situation, according to a September 28, 2016 The New York Times report.

CMS, an agency that is part of the Health and Human Services (HHS) Department, issued a rule to ban nursing homes that receive federal funding from mandating residents to resolve disputes in arbitration, bypassing court. Nursing home admissions contract clauses have kept issues about quality and safety away from public view. The system enabled a lowering of legal costs in the nursing home industry and hindered residents’ families from receiving justice, according to The New York Times. “The sad reality is that today too many Americans must choose between forfeiting their legal rights and getting adequate medical care,” Senator Patrick Leahy, a Democrat of Vermont, said in a statement.

The new rule followed a move by officials in 16 states and the District of Columbia who prompted the government to cease nursing home funding that uses the clauses. The group argued that arbitration was not allowing information on cases of abuse, neglect, and harassment to be available to prospective residents and their families, The New York Times noted. Arbitrations are confidential, and no federal database exists that records arbitration outcomes. Meanwhile, The New York Times, as part of a year long investigation, reviewed more than 25,000 arbitration records from 2010 through and 2014 and interviewed hundreds of lawyers, arbitrators, plaintiffs, and judges in 35 states and “found many troubling examples” in which “issues of abuse and potential neglect” were never made public “because they were blocked from court.”

“Nursing home abuse is one of the most devastating horrors taking place in the elder community and impacting our older, vulnerable loved ones, who are often unable to defend themselves,” said Keith Gitman, Managing Attorney at Parker Waichman.

“This monumental success on behalf of nursing home residents’ rights was also achieved with the help of New York’s United States Senators and our Attorney General, who signed letters urging CMS to establish this important new requirement,” said Edward H. Gersowitz: President, New York State Trial Lawyers Association (NYSTLA).

According to NYSTLA, the move does not allow a facility to enter into a pre-dispute agreement for binding arbitration with a resident or resident’s representative and must not mandate that a resident sign an arbitration agreement as a condition of admission to the facility. Should a dispute arise—and if a facility asks a resident or his/her representative to enter into a binding arbitration agreement—the facility must comply with the requirements in the new rule. The agreement must be explained to the resident and resident representative “in a form and manner that he or she understands, including in a language the resident and their representative understands: and that the resident ‘acknowledges that he or she understands the agreement.’” A resident’s right to remain in the facility “must not be contingent upon the resident or the resident’s representative signing a binding arbitration agreement,” nor can the agreement contain language that “prohibits or discourages the resident or anyone else from communicating with federal, state, or local officials.”

To determine whether your or a loved one may have a claim for allege nursing home abuse, neglect, harassment, or other injury, please visit the Parker Waichman’s website or call 1-800-LAW-INFO (1-800-529-4636).

###

Contact Parker Waichman LLP:

Parker Waichman
516-466-6500
info@yourlawyer.com
6 Harbor Park Drive Port Washington, NY 11050

ReleaseID: 60012639

The latest market report published by Credence Research, Inc. “Global Drug Abuse Testing/ Screening Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the drug abuse testing/screening market was valued at USD 3,303.4 Mn in 2015, and is expected to reach USD 4,555.9 Mn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022.

Browse the full report Drug Abuse Testing/Screening Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/drug-of-abuse-testing-screening-market

Market Insights

The American Society of Addiction Medicine (ASAM) suggests that, the most important contribution of the scientific study of addiction in the last half century has been the new understanding of the neurobiology of brain reward. In addition, the article titled “An Overview of Present and Future Drug Testing”, authored by David M. Martin and published in The Journal of Global Drug Policy and Practice explains that, over the past 30 years drug testing has evolved from a series of obscure laboratory tests to a multibillion dollar global industry that is constantly observed in day to day life.

Drug of abuse testing is related to diagnosis of drug addiction that requires a thorough evaluation and mainly comprises assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. The samples used for drug testing are blood, oral fluids, urine or others. The testing technologies consist of immunoassay technique and chromatography technique, used for both onsite as well as laboratory testing. On the basis of type of location, the market is segmented into laboratory-based screening and onsite screening.

Laboratory based tests requires skilled and trained personnel for providing detailed analysis. Whereas, onsite drugs of abuse testing provide immediate results. The key factors assisting the growth of drug of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse.

Market Competition Assessment

The drug of abuse testing or screening market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere, Inc., Abbott Laboratories, Randox laboratories, Psychemedics Corporation, Bio-Rad Laboratories, Sonic Healthcare and Thermo Fisher Scientific.

Browse the full report Drug Abuse Testing/Screening Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/drug-of-abuse-testing-screening-market

Key Market Movements

Urine Drug Tests are the most common test type used in the drug of abuse testing. Currently, hair as a specimen, is also becoming a more effective way for testing long term drug use
According to Quest Diagnostics, the percentage of American workers testing positive for illicit drugs such as marijuana, cocaine and methamphetamine has increased for the second consecutive year in the general U.S. workforce, according to insights from more than 10 million workplace drug test results.

Latest Reports:

Microbiome Therapeutics Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Alopecia Treatment Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Parenteral Nutrition Market By Type (Carbohydrates, Amino Acids, Lipids, Electrolytes) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

The post Global Drug Abuse Testing / Screening Market is Expected to Reach USD 4,555.9 Mn by 2022 – Credence Research appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3604

Global smart inhalers market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022, in the moderate growth scenario. Smart inhalers are also known as connected inhalers andsensors and are mainly used as clip-on sensors, which are attached over a normal inhaler (DPIs, MDIs) or nebulizers for the treatment of asthma and COPD. Smart inhalers as defined in this report are defined as devices providing data wirelessly through cloud, internet, or mobile apps. They track the usage of the dose as and when taken by the patients and also alert the patients through timely reminders. Under the scope of study, the report only considers devices that provides data digitally and excludes devices such as traditional inhalers or which do not use smart inhalers. In addition, smart inhalers available for commercial use as well as smart inhalers used for research and development are considered in the report.

Browse Full Report Visit – http://www.acutemarketreports.com/report/smart-inhalers-market

The Global smart inhalers market is segmented under three different scenarios: moderate growth scenario, rapid growth scenario, and diminishing growth scenario.

Market growth is attributed to the increase in air pollution, incidence of respiratory diseases such as asthma and COPD, and healthcare burden, due to higher cases of asthma and COPD. In addition, probable increase in adherence to smart inhalers is an additional factor for the growth. However, high cost of asthma and COPD treatment, limited availability of smart inhalers, and misuse of data are expected to restrain the market growth.

TOP INVESTMENT POCKETS:

The smart inhalers market is based on three different scenarios, and therefore top investment pockets have been mentioned with respect to the moderate growth scenario.

North America accounted for the maximum revenue due to wider availability of smart inhalers coupled with wider government initiatives, growth in demand for advanced technology, and increase in use of mobile phones. Smart inhalers directly transfer data related to the medications to the mobile app as well as to the cloud server through the Internet. Therefore, higher use of mobile phones coupled with rise in cases of asthma and COPD in this region act as major growth opportunities for the smart inhalers market.

Inhalation route is the fastest and most effective method of delivering medications to the respiratory system to treat COPD and asthma. These medications are delivered orally through inhalers; however, patients and users tend to forget or miss the dose for the indication. This has led to the development of smart inhalers, which can be easily attached to the patients inhaler and monitor adherence as well as record the time of each dose when taken. Smart inhalers have emerged as a novel approach in asthma and COPD management and are expected to be a potential factor in the growth of the market.

Browse All Reports of This Category – http://www.acutemarketreports.com/category/medical-equipments-market

REGIONAL AND COUNTRY OVERVIEW:

Europe has emerged as the second preferred market for smart inhaler products. Novartis, AstraZeneca, and Boehringer Ingelheim are key players the European region. Adoption of these smart inhalers, by hospitals and patients boosts the market growth. Moreover, the European Academy of Allergy & Clinical Immunology is continuously making efforts to increase awareness about asthma and COPD.In the year 2015, the leading revenue-generating region was North America, whereas Asia-Pacific is projected to grow at a significant CAGR of 65.3% during the forecast period, due to rise in demand for smart inhalers and increase in cases of COPD and asthma. Asia-Pacific is the potential market for growth of smart inhalers due to high population base, high disposable incomes, and rise in patient awareness, and increase in prevalence of asthma and COPD.

The Turkish smart inhalers market was valued at $30 thousand in 2015, and is expected to reach $1,090 thousand by 2022, with a CAGR of 65.3% during the forecast period.

Adherium is the leading player in the smart inhaler market with majority product approvals. However, smart inhalers being a lucrative market, acquisitions & collaborations between the pharmaceutical companies, medical device companies, and smart inhaler manufacturers are increasing to capture market space. Increase in collaborations between pharmaceutical companies and smart inhalers manufacturers, such as collaboration between Adherium & AstraZeneca; and GSK partnering with Propeller Health, have led competition in the industry. Major players have adopted product approval and clinical trials as their key development strategies. Important players operating in this market include Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group plc., Boehringer Ingelheim GmbH, AstraZeneca plc, Cohero Health, LLC; Propeller Health, OPKO Health, Inc. (Inspiro Medical Ltd.), Adherium Limited, Novartis AG, and GlaxoSmithKline plc.

SMART INHALERS MARKET KEY BENEFITS

Competitive landscape section includes major players operating within the smart inhalers market, with key strategies adopted by them to achieve high monetary value.
The report also provides quantitative as well as qualitative trends to assist the stakeholders to understand the situations prevailing in the market.
Entire projections presented in the report are based on analysis of the current trends and highlight the market potential from 2016 to 2022, both in terms of value and volume.
The report provides an in-depth analysis of the estimated revenues generated by smart inhalers as well as major geographies during the forecast period.

Chapter: 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO Perspective

Chapter: 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Key Findings
3.2.1 Top Winning Strategies
3.2.2 Top Investment Pockets
3.3 Porter’s Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Intensity of Competitive Rivalry
3.4 Top Player Positioning, 2015
3.5 Clinical Trials
3.6 Product Portfolio
3.7 Market Dynamics

Chapter: 4 SMART INHALERS MARKET, BY PRODUCT, 2014–2022
4.1 Overview
4.1.1 Market Size and Forecast
4.2 Inhalers
4.2.1 Key Market Trends
4.2.2 Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 Dry Powder Inhalers (DPIs)
4.2.5 Metered Dose Inhalers (MDIs)
4.3 Nebulizers
4.3.1 Key Market Trends
4.3.2 Growth Factors and Opportunities
4.3.3 Market Size and Forecast

Chapter: 5 SMART INHALERS MARKET, BY INDICATION, 2014–2022
5.1 Overview
5.1.1 Market Size and Forecast
5.2 Asthma
5.2.1 Market Size and Forecast
5.3 COPD
5.3.1 Market Size and Forecast

Chapter: 6 SMART INHALERS MARKET, BY END USER, 2014–2022
6.1 Overview
6.1.1 Market Size and Forecast
6.2 Patients
6.2.1 Market Size and Forecast
6.3 R&D
6.3.1 Market Size and Forecast

Browse For Complete Report Here : Global Smart Inhalers Market 2016

Chapter: 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014–2022
7.1 Overview
7.1.1 Market Size and Forecast
7.2 North America
7.2.1 Key Market Trends
7.2.2 Growth Factors and Opportunities
7.2.3 Market Size and Forecast
7.2.3.1 U.S.: Market Size and Forecast
7.2.3.2 Canada: Market Size and Forecast
7.2.3.3 Mexico: Market Size and Forecast

Latest Reports

World 3D Printing Market – Opportunities and Forecasts 2014 – 2020

Mobile Security Asia-Pacific Market Research Report, 2014 – 2020

Asia-Pacific LED Market – Opportunities and Forecast, 2014 – 2020
About – Acute Market Reports :

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us : 
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com

The post Recent Release : Global Smart Inhalers Market Size, Share, Trend, Growth, Analysis and Forecast Report 2016 – Acute Market Reports appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3601

According to the latest report published by Credence Research, Inc. “Hospital Acquired Disease Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the hospital acquired disease testing market was valued at USD 523.0 Mn in 2015, and is expected to reach USD 1,630.0 Mn by 2022, expanding at a CAGR of 5.4% from 2016 to 2022.

Market Insights

Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.

Browse the full report Hospital Acquired Disease Testing: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/hospital-acquired-disease-testing-market

The global hospital acquired disease testing market is categorized into tests for hospital acquired pneumonia, urinary tract infection, surgical site infection, bloodstream infection, MRSA and others. Hospital acquired pneumonia and urinary tract infection together occupy more over 50% market share in 2015 with a larger set of revenue coming from urinary tract infection. The prevalence and morbidity associated with urinary tract infection is the highest among the other infection types and its diagnosis is the swiftest. It is anticipated that the dominance of this segment will continue through the forecast period 2016-2022. Other testing tools for surgical site infections and bloodstream infection are anticipated to undergo faster growth during the forecast period attributed by their alarming incidence in the emerging markets.

Geographically, North America is the largest regional market for hospital acquired disease testing, high number of hospital stays and the corresponding risk of contracting HAIs majorly determine the market size of this region. On the other hand, greater awareness and reducing the incidence of hospital readmission, along with the growing urgency to control hospital and healthcare costs contribute to the faster market growth rate of Asia-Pacific and Latin America hospital acquired disease testing markets.

Browse the full report Hospital Acquired Disease Testing: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/hospital-acquired-disease-testing-market

In view of the market competition, this market is fragmented with a multitude of companies offering HAI testing tools. Some of the notable players in the hospital acquired disease testing market include Diatherix Corp, Roche, Cantel Medical Corporation, Qiagen, Cephid, bioMeriux and others.

Latest Reports:

Angina Pectoris Treatment Market By Drug Type (Antiplatelet agents, Beta-adrenergic blocking agents, Calcium channel blockers, Short & Long – acting Nitroglycerines, Angiotensin-converting enzyme inhibitors, Anti-ischemic agents) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Drug Delivery Technologies Market By Application (Oral, Pulmonary, Transdermal, Injectable, Nasal, Implantable & Others) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Video Conferencing in Healthcare Market By Deployment Model (On-premise Video Conferencing, Cloud-based Video Conferencing, Managed Video Conferencing Services) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

The post Global Hospital Acquired Disease Testing Market to Reach Worth USD 1.6 Bn by 2022 – Credence Research appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3606